Table 3.
The ADME profiles of the 51 phytochemicals that showed antioxidant, anti-inflammatory, and antibacterial activities in the PASS program.
| Peak No. | Compounds name | Compound CID | Canonical SMILES |
Absorption |
Distribution |
Metabolism |
Excretion |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CYP450 inhibitor |
CYP450 substrate |
|||||||||||||||
| HIA | HOB | p-glycoprotein inhibitor | p-glycoprotein substrate | BBB penetration | PPB (%) | CYP4502C9 | CYP4502D6 | CYP4503A4 | CYP4502C9 | CYP4502D6 | CYP4503A4 | Renal clearance (ml/min/kg) | ||||
| 3 | 1,1-Cyclohexanedimethanol | 250594 | C1CCC(CC1)(CO)CO | + | + | NI | NS | − | 19.524 | NI | NI | NI | NS | NS | NS | 6.556 (Moderate) |
| 6 | 4-Cyclopentene-1,3-dione | 70258 | C1C(=O)C]CC1=O | + | + | NI | NS | − | 57.697 | NI | NI | NI | NS | NS | NS | 8.913 (Moderate) |
| 11 | O-Xylene | 7237 | CC1=CC]CC]C1C | + | + | NI | NS | − | 89.002 | NI | NI | NI | NS | NS | NS | 10.483 (Moderate) |
| 12 | 1,3,5,7-Cyclooctatetraene | 637866 | C1=CC]CC]CC]C1 | + | + | NI | NS | − | 84.437 | NI | NI | NI | NS | NS | NS | 2.413 (Low) |
| 13 | 2-Furanone | 10341 | C1C]CC(=O)O1 | + | + | NI | NS | − | 79.219 | NI | NI | NI | NS | NS | NS | 14.220 (Moderate) |
| 14 | 2,6,6-Trimethylbicyclo [3.1.1] heptane-3-ol or Isopinocampheol or 3-Pinanol | 99038 | CC1C2CC(C2(C)C)CC1O | + | + | NI | NS | − | 54.637 | NI | NI | NI | NS | NS | NS | 15.208 (High) |
| 17 | 5-Methylfuran-2-carbaldehyde or 5-Methyl furfural | 12097 | CC1=CC]C(O1)C]O | + | + | NI | NS | − | 70.804 | NI | NI | NI | NS | NS | NS | 6.582 (Moderate) |
| 18 | 3-Hydroperoxyhexane or 3-Hexyl hydroperoxide | 141085 | CCCC(CC)OO | + | + | NI | NS | − | 59.289 | NI | NI | NI | NS | NS | NS | 8.870 (Moderate) |
| 23 | 3-Methoxy-2- (methoxymethyl)-2-methylpropan-1-ol | 542357 | CC(CO)(COC)COC | + | + | NI | NS | − | 11.982 | NI | NI | NI | NS | NS | NS | 5.628 (Moderate) |
| 25 | 5-(2-Ethyl-1,3,2-dioxaborolan-4-yl)-3,4-dihydroxyfuran-2(5H)-one | 54685836 | B1(OCC(O1)C2C(=C(C(=O)O2)O)O)CC | + | + | NI | NS | − | 85.147 | NI | NI | NI | NS | NS | NS | 11.526 (Moderate) |
| 28 | Benzyl alcohol | 244 | C1=CC]C(C]C1)CO | + | + | NI | NS | − | 51.396 | NI | NI | NI | NS | NS | NS | 9.037 (Moderate) |
| 32 | 2,3,4,6,7,8-Hexahydropyrrolo[1,2-a]pyrimidine | 76349 | C1CC2 = NCCCN2C1 | + | + | NI | NS | − | 45.148 | NI | NI | NI | NS | NS | NS | 12.065 (Moderate) |
| 35 | 3-(Hydroxy-phenyl-methyl)-2,3-dimethyl-octan-4-one | 559104 | CCCCC(=O)C(C)(C(C)C)C(C1=CC]CC]C1)O | + | + | NI | NS | − | 91.190 | NI | NI | NI | NS | NS | NS | 10.550 (Moderate) |
| 37 | Phenylethyl alcohol | 6054 | C1=CC]C(C]C1)CCO | + | + | NI | NS | − | 53.125 | NI | NI | NI | NS | S | NS | 10.085 (Moderate) |
| 42 | 5-(Hydroxymethyl)furan-2-carbaldehyde or 5-hydroxymethylfurfural | 237332 | C1=C(OC(=C1)C]O)CO | + | + | NI | NS | − | 50.357 | NI | NI | NI | NS | NS | NS | 7.185 (Moderate) |
| 43 | Resorcinol | 5054 | C1=CC(=CC(=C1)O)O | + | + | NI | NS | − | 44.189 | NI | NI | NI | NS | NS | NS | 16.027 (High) |
Here, “+” and “−” means present and absent, respectively; I = Inhibitor; NI = Noninhibitor; NS = Non-substrate; S = Substrate.